Attached files
| file | filename |
|---|---|
| EX-10.27 - EX-10.27 - Dicerna Pharmaceuticals Inc | d851674dex1027.htm |
| EX-31.1 - EX-31.1 - Dicerna Pharmaceuticals Inc | d851674dex311.htm |
| EX-31.2 - EX-31.2 - Dicerna Pharmaceuticals Inc | d851674dex312.htm |
| EX-21.1 - EX-21.1 - Dicerna Pharmaceuticals Inc | d851674dex211.htm |
| EX-10.28 - EX-10.28 - Dicerna Pharmaceuticals Inc | d851674dex1028.htm |
| EX-10.25 - EX-10.25 - Dicerna Pharmaceuticals Inc | d851674dex1025.htm |
| EX-10.26 - EX-10.26 - Dicerna Pharmaceuticals Inc | d851674dex1026.htm |
| EX-10.29 - EX-10.29 - Dicerna Pharmaceuticals Inc | d851674dex1029.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Dicerna Pharmaceuticals Inc | Financial_Report.xls |
| 10-K - FORM 10-K - Dicerna Pharmaceuticals Inc | d851674d10k.htm |
| EX-32.1 - EX-32.1 - Dicerna Pharmaceuticals Inc | d851674dex321.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-193795 on Form S-8 of our report dated March 12, 2015, relating to the consolidated financial statements of Dicerna Pharmaceuticals, Inc. and its subsidiaries appearing in this Annual Report on Form 10-K of Dicerna Pharmaceuticals, Inc. for the year ended December 31, 2014.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 12, 2015